Showing results (281-290 of 330) with videos related to
Sort By:
Pageof 33
The New England Journal of Medicine|September 16, 2024
Preoperative Chemoradiotherapy for Resectable Gastric CancerTrevor Leong, B Mark Smithers, Michael Michael, et al.International Journal of Cancer|November 22, 2021
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3)Markus Moehler, Gunnar Folprecht, Volker Heinemann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancerMarc Peeters, Timothy Jay Price, Andrés Cervantes, et al.The Oncologist|March 9, 2021
Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease CourseJeannette Vogt, Franziska Beyer, Jochen Sistermanns, et al.BMC Cancer|June 12, 2022
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globallyTessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, et al.Lancet (London, England)|April 17, 2023
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trialKohei Shitara, Florian Lordick, Yung-Jue Bang, et al.Future Oncology (London, England)|July 19, 2022
T cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancerManish A Shah, Takashi Kojima, Daniel Hochhauser, et al.European Journal of Cancer (Oxford, England : 1990)|February 7, 2025
Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi studyDenice Kamp, Anne M May, Antoine Adenis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2021
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and OxaliplatinElisa Fontana, Jeff Meyers, Alberto Sobrero, et al.United European Gastroenterology Journal|March 28, 2020
Gastric cancer in autoimmune gastritis: A case-control study from the German centers of the staR project on gastric cancer researchFriederike Weise, Michael Vieth, Dirk Reinhold, et al.Pageof 33